The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Johnson & Johnson; Merck Sharp & Dohme
Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).
 
Naomi B. Haas
Consulting or Advisory Role - AVEO; Calithera Biosciences; Eisai; Exelixis; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Expert Testimony - Lilly (I)
 
Rituparna Bhattacharya
Employment - Merck; Otsuka (I)
 
Yan Song
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
Jackie Rogerio
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Patent pending as a Merck emplyee
 
Su Zhang
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
Christopher Carley
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
Annika Anderson
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
James Signorovitch
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
Murali Sundaram
No Relationships to Disclose